AU2001290772A1 - Alpha v integrin receptor antagonists - Google Patents
Alpha v integrin receptor antagonistsInfo
- Publication number
- AU2001290772A1 AU2001290772A1 AU2001290772A AU9077201A AU2001290772A1 AU 2001290772 A1 AU2001290772 A1 AU 2001290772A1 AU 2001290772 A AU2001290772 A AU 2001290772A AU 9077201 A AU9077201 A AU 9077201A AU 2001290772 A1 AU2001290772 A1 AU 2001290772A1
- Authority
- AU
- Australia
- Prior art keywords
- alpha
- receptor antagonists
- integrin receptor
- integrin
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23226200P | 2000-09-14 | 2000-09-14 | |
| US60232262 | 2000-09-14 | ||
| PCT/US2001/028404 WO2002022616A2 (en) | 2000-09-14 | 2001-09-10 | Alpha v integrin receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001290772A1 true AU2001290772A1 (en) | 2002-03-26 |
Family
ID=22872445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001290772A Abandoned AU2001290772A1 (en) | 2000-09-14 | 2001-09-10 | Alpha v integrin receptor antagonists |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020040030A1 (en) |
| AU (1) | AU2001290772A1 (en) |
| WO (1) | WO2002022616A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2424304A1 (en) * | 2000-10-05 | 2002-04-11 | Merck & Co., Inc. | Process for preparation of integrin receptor antagonist intermediates |
| CN102026671B (en) | 2008-03-14 | 2014-09-03 | Visen医药公司 | Integrin targeting reagents and in vivo and in vitro imaging methods using the same |
| JP5622565B2 (en) * | 2008-03-28 | 2014-11-12 | 武田薬品工業株式会社 | Stable vinamidinium salts and nitrogen-containing heterocycle synthesis using them |
| HUE035357T2 (en) | 2013-02-07 | 2018-05-02 | Scifluor Life Sciences Inc | Fluorinated integrin antagonists |
| US8901144B2 (en) | 2013-02-07 | 2014-12-02 | Scifluor Life Sciences, Llc | Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives |
| GB201305668D0 (en) | 2013-03-28 | 2013-05-15 | Glaxosmithkline Ip Dev Ltd | Avs6 Integrin Antagonists |
| LT3929196T (en) | 2013-09-24 | 2023-09-25 | Fujifilm Corporation | Pharmaceutical composition of a nitrogen-containing compound or salt thereof, or metal complex thereof |
| GB201417011D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417094D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417018D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417002D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| KR102647026B1 (en) | 2015-02-19 | 2024-03-12 | 사이플루어 라이프 사이언시즈, 인크 | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof |
| GB201604680D0 (en) | 2016-03-21 | 2016-05-04 | Glaxosmithkline Ip Dev Ltd | Chemical Compounds |
| US11046685B2 (en) | 2017-02-28 | 2021-06-29 | Morphic Therapeutic, Inc. | Inhibitors of (α-v)(β-6) integrin |
| BR112019017929A2 (en) | 2017-02-28 | 2020-05-19 | Morphic Therapeutic Inc | integrin (alpha-v) (beta-6) inhibitors |
| HUE071053T2 (en) | 2018-08-29 | 2025-07-28 | Morphic Therapeutic Inc | Inhibitors of alpha v beta6 integrin |
| EP4086254B1 (en) | 2018-08-29 | 2024-12-18 | Morphic Therapeutic, Inc. | Integrin inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048861A (en) * | 1997-12-17 | 2000-04-11 | Merck & Co., Inc. | Integrin receptor antagonists |
| CN1284944A (en) * | 1997-12-17 | 2001-02-21 | 麦克公司 | Integrin receptor antagonists |
| HUP0302468A2 (en) * | 1999-06-02 | 2003-11-28 | Merck & Co., Inc. | Alpha v integrin receptor antagonists and pharmaceutical compositions containing them |
-
2001
- 2001-09-10 WO PCT/US2001/028404 patent/WO2002022616A2/en not_active Ceased
- 2001-09-10 AU AU2001290772A patent/AU2001290772A1/en not_active Abandoned
- 2001-09-14 US US09/953,606 patent/US20020040030A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020040030A1 (en) | 2002-04-04 |
| WO2002022616A2 (en) | 2002-03-21 |
| WO2002022616A3 (en) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001269876A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
| IL153308A0 (en) | Thrombin receptor antagonists | |
| EP1105389A4 (en) | Integrin receptor antagonists | |
| AU3213799A (en) | Integrin antagonists | |
| AU2001294547A1 (en) | Substituted urea neuropeptide y y5 receptor antagonists | |
| AU8689798A (en) | Integrin receptor antagonists | |
| IL152700A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists | |
| AU2001290772A1 (en) | Alpha v integrin receptor antagonists | |
| AU2001234741A1 (en) | Integrin antagonists | |
| AU9259801A (en) | Alpha v integrin receptor antagonists | |
| AU2001271435A1 (en) | Vitronectin receptor antagonist pharmaceuticals | |
| AU2541000A (en) | Beta-phenylalanine derivatives as integrin antagonists | |
| AU2441801A (en) | Urotensin-ii receptor antagonists | |
| AU6990000A (en) | Novel integrin receptor antagonists | |
| AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
| AU2001245724A1 (en) | Il-8 receptor antagonists | |
| AU2001240021A1 (en) | Diazafluorenone il-8 receptor antagonists | |
| AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
| AU2002216079A1 (en) | Bombesin receptor antagonists | |
| AU2001243351A1 (en) | Il-8 receptor antagonists | |
| AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
| IL146146A0 (en) | Integrin receptor antagonists | |
| AU2001249573A1 (en) | Chemokine receptor antagonists | |
| AU5861900A (en) | Receptor agonists and antagonists | |
| AU2001241896A1 (en) | Il-8 receptor antagonists |